Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Myelodysplastic syndrome (MDS) refers to a group of blood and bone marrow cancers. It develops when a person has low levels of certain types of blood cell in their body. Healthcare professionals used ...

Myelodysplastic syndromes (MDS) are blood cancers caused by an insufficient production of healthy blood cells. Production of irregular cells leads to anemia, where the body’s organs and tissues don’t ...

Fred Hutchinson Cancer Center is a world leader in Myelodysplastic Syndrome (MDS) research. Our experts are developing innovative ways to detect and diagnose MDS, unraveling how MDS progresses to ...

Myelodysplastic syndromes (MDS) are a group of related conditions that interfere with the body’s ability to make healthy blood cells. They are a type of blood cancer. In the early stages of ...

Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas Myelodysplastic syndrome (MDS) classification currently relies mainly on its morphologic features and ...